What is the Argenica Therapeutics (ASX: AGN) share price?
The AGN share price is $0.11, up 0.00% for the day, based on the latest available ASX market data.
What is Argenica Therapeutics's market capitalisation?
Argenica Therapeutics has a market capitalisation of $14.1M, making it the 1410th-largest security listed on the ASX.
Does Argenica Therapeutics pay a dividend?
AGN does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Argenica Therapeutics profitable?
In its most recent reported period (ending 31 Dec 2025), AGN reported revenue of $0 and a net loss of $3.8M.
How many AGN shares are on issue?
Argenica Therapeutics has approximately 128,456,709 shares on issue, based on its market capitalisation of $14.1M and current share price.
What sector is Argenica Therapeutics in?
Argenica Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Argenica Therapeutics list on the ASX?
Argenica Therapeutics listed on the Australian Securities Exchange on 11 June 2021.
